Document is current
Any future updates will be listed below
-
Authors
Inaki, Anri https://orcid.org/0000-0003-1209-7164
Shiga, Tohru
Tsushima, Yoshito
Jinguji, Megumi
Wakabayashi, Hiroshi
Kayano, Daiki
Akatani, Norihito
Yamase, Takafumi
Kunita, Yuji
Watanabe, Satoru
Hiromasa, Tomo
Mori, Hiroshi
Hirata, Kenji
Watanabe, Shiro
Higuchi, Tetsuya
Tomonaga, Hiroyasu
Kinuya, Seigo
-
Funding
Funding for this research was provided by:
FUJIFILM Toyama Chemical Co., Ltd.
- License Information
-
More Information
Article History
Received: 20 September 2021
Accepted: 17 November 2021
First Online: 6 December 2021
Declarations
:
: A. Inaki is a member of the working group for preparation of the proper use manual of <sup>131</sup>I-mIBG, managed by FUJIFILM Toyama Chemical Co., Ltd., and has performed collaborative research with FUJIFILM Toyama Chemical Co., Ltd., developing <sup>131</sup>I-mIBG therapy for patients with high-risk neuroblastoma. S. Watanabe belongs to a department that is partly funded by FUJIFILM Toyama Chemical Co., Ltd.
